Berberine
The plant alkaloid acting as nature's metformin
Definition
Berberine is a yellow isoquinoline alkaloid extracted from roots and bark of plants such as Coptis chinensis, Berberis vulgaris, and Hydrastis canadensis, used in traditional Chinese medicine for centuries. Its modern metabolic effects are well documented: it activates AMPK, lowers fasting glucose, improves HbA1c and lipid profile with efficacy comparable to metformin in head-to-head studies. It is one of the most evidence-backed supplements in metabolism.
Detailed explanation
A meta-analysis published in Evidence-Based Complementary and Alternative Medicine pooling 27 randomised clinical trials (n=2,569) confirmed that berberine at doses of 0.5-1.5 g/day for 2-3 months lowers fasting glucose 0.84 mmol/L, HbA1c 0.71%, total cholesterol 0.61 mmol/L, LDL 0.65 mmol/L, and triglycerides 0.5 mmol/L, with a safety profile equivalent or better than metformin (fewer severe GI side effects).
Confirmed mechanisms: AMPK activation (similar to metformin), inhibition of dipeptidyl peptidase-4 (DPP-4, mechanism of gliptins), modulation of the gut microbiota (increased Akkermansia muciniphila), and reduction of metabolic endotoxemia (LPS).
Oral bioavailability is very low (≈5%) due to hepatic metabolism and intestinal efflux by P-glycoprotein. Modern formulations — Dihydroberberine and berberine with silymarin — increase bioavailability 3-5×. Typical dosing: 500 mg 2-3 times daily with meals. Contraindications: pregnancy, breastfeeding, and concomitant ciclosporin use.
Scientific sources
- PubMed — Efficacy of berberine in patients with type 2 diabetes mellitus: a meta-analysis
- PubMed — Berberine is a novel cholesterol-lowering drug working through a unique mechanism
- PubMed — Berberine and AMPK activation: implications for metabolic disease
- PubMed — Berberine modulates gut microbiota and reduces metabolic endotoxemia
Interested in related treatments?
Generate My Protocol